Telogen Effluvium Following the Treatment of Euglycemic Diabetic Ketoacidosis in a Patient With Heavy Soft Drink Intake: A Case Report
October 2024
in “
Cureus
”
Studysummary This case report explores a 28-year-old man with type 2 diabetes who experienced telogen effluvium, a type of hair loss, following treatment for euglycemic diabetic ketoacidosis with luseogliflozin, possibly triggered by physical stress related to his condition and treatment.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on assets.cureus.com →